Skip to content
stoqly

Scotts Miracle-Gro

SMG NYSE Fertilizers & Agricultural Chemicals Financials FY2016–FY2025

Scotts Miracle-Gro's revenue fell 3.9% to $3.4 billion in fiscal 2025. Its operating margin was 10.5%, up from 5.9% a year earlier. Free cash flow was $274 million, down 53.1%. It paid out $173 million in dividends and buybacks, 63% of free cash flow. The diluted share count rose 3.4%.

Last close Β· Oct 23, 2026

$59.29

0.2%
Revenue Total sales reported in the income statement.
$3.4B
3.9% vs prior year
Operating margin Operating income as a share of revenue.
10.5%
4.6 pts
Net income Profit after all expenses, interest and tax.
$145M
Free cash flow Cash from operations minus capital spending.
$274M
53.1%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
13.4%
5.4 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$3.5B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
50.3x
On $1.18 EPS (TTM)

What Scotts Miracle-Gro does

No business description yet.

Legal name
Scotts Miracle-Gro Co
Fiscal year ends
September 30, 2025
Latest annual report
β€”
Accession Β· CIK
0000825542-25-000022
0000825542

Revenue and margins

Scotts Miracle-Gro had $3.4B of revenue in fiscal 2025, down 3.9% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew βˆ’7.7% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $274M in fiscal 2025, 8.0% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Scotts Miracle-Gro returned $173M to shareholders in fiscal 2025, 63% of free cash flow. The diluted share count rose 3.4%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Scotts Miracle-Gro yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β€” the answer depends entirely on what you put in.

Discounted cash flow

Value per share

β€”

Adds net cash of βˆ’$2.1B and divides by 58.7M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

β€”

Reference multiples: today 50.2x Β· peers 8.6x Β· sector 20.1x.

Balance sheet

Cash, debt and the ratios that show how comfortably Scotts Miracle-Gro can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $244M$86.8M$31.9M$71.6M$36.6M
Debt incl. finance leases $2.3B$3.0B$2.6B$2.2B$2.1B
Net debt / EBITDA 2.5xβ€”β€”7.5x4.8x
Debt / equity 2.3xβ€”β€”β€”β€”
Interest coverage 9.2xβˆ’3.7xβˆ’1.0x1.3x2.8x
Current ratio 1.8x2.1x1.8x1.3x1.3x
Quick ratio 0.8x0.7x0.7x0.5x0.5x
Total assets $4.8B$4.3B$3.4B$2.9B$2.7B
Total liabilities $3.8B$4.1B$3.7B$3.3B$3.1B
Shareholders' equity $1.0B$148Mβˆ’$267Mβˆ’$391Mβˆ’$358M
Net debt (βˆ’ = net cash) $2.1B$2.9B$2.6B$2.2B$2.1B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

1 insider

Sold, 12 months

$5.5M

3 insiders

Of sales under plans

0%

$0.0M

DateInsiderTradeSharesPriceValueFiling
Aug 10, 2026 Mark D KingdonDirector Sold 831 $61.65 $0.1M Form 4
Aug 3, 2026 Hagedorn Partnership L.P.Director, 10% owner Sold 30,000 $67.45 $2.0M Form 4
Jul 30, 2026 Stephen L JohnsonDirector Sold 1,171 $68.32 $0.1M Form 4
Feb 24, 2026 Mark J ScheiwerEVP, CFO & CAO Bought 693 $71.44 $0.0M Form 4
Feb 12, 2026 Hagedorn Partnership L.P.Director, 10% owner Sold 50,000 $66.40 $3.3M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive βœ• βœ• βœ“
Cash from operations is positive βœ“ βœ“ βœ“
Return on assets rose βœ“ βœ“ βœ“
Cash from operations exceeds net income βœ“ βœ“ βœ“
Debt fell relative to assets βœ• βœ• βœ•
Current ratio rose βœ• βœ• βœ•
Share count didn't rise βœ• βœ• βœ•
Gross margin rose βœ• βœ“ βœ“
Revenue rose relative to assets βœ“ βœ“ βœ“
F-score 4 / 95 / 96 / 9
Accruals ratio βˆ’23.6%βˆ’22.4%βˆ’8.1%
Altman Z'' 1.251.231.59

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Scotts Miracle-Gro SMG $3.5B βˆ’3.9% 10.5% 8.0% 13.4% 50.3x 6
FMC FMC $633M βˆ’18.3% βˆ’47.0% βˆ’3.0% βˆ’19.6% β€” 2 Compare β†’
CF Industries CF $18.6B 19.3% 32.5% 25.4% 20.6% 9.0x 8 Compare β†’
Mosaic MOS $5.7B 8.4% 6.8% βˆ’4.4% 2.5% β€” 8 Compare β†’
Corteva CTVA $8.3B 2.9% β€” 16.2% 5.8% 8.2x 8 Compare β†’

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $2.5B $2.6B $2.7B $3.2B $4.1B $4.9B $3.9B $3.6B $3.6B $3.4B
Gross profit $900M $973M $865M $1.0B $1.3B $1.5B $873M $657M $851M $1.0B
Research and development $36.0M $39.9M $42.5M $39.6M $39.7M $45.4M $45.3M $35.7M $34.6M $34.8M
Operating income $448M $433M $199M $410M $585M $723M βˆ’$434M βˆ’$174M $209M $359M
Interest expense $62.9M $76.1M $86.4M $102M $79.6M $78.9M $118M $178M $159M $129M
Pretax income $384M $315M $116M $582M $511M $677M βˆ’$558M βˆ’$453M βˆ’$23.6M $222M
Income tax $138M $117M βˆ’$11.9M $145M $124M $160M βˆ’$121M βˆ’$73.2M $11.3M $76.5M
Net income $315M $218M $63.7M $461M $387M $513M βˆ’$438M βˆ’$380M βˆ’$34.9M $145M
Diluted EPS $5.09 $3.63 $1.12 $8.18 $6.81 $8.96 βˆ’$7.88 βˆ’$6.79 βˆ’$0.61 $2.47
Diluted shares 0.06B 0.06B 0.06B 0.06B 0.06B 0.06B 0.06B 0.06B 0.06B 0.06B
Cash flow
Cash from operations $244M $363M $343M $227M $558M $272M βˆ’$129M $531M $668M $371M
Capital expenditure $58.3M $69.6M $68.2M $42.4M $62.7M $107M $114M $92.8M $84.0M $97.4M
Free cash flow $186M $294M $274M $184M $495M $165M βˆ’$243M $438M $584M $274M
Depreciation and amortization $62.3M $73.8M $83.4M $89.3M $94.7M $93.8M $105M $92.5M $80.6M $75.0M
Stock-based compensation $15.6M $25.2M $40.4M $38.4M $57.9M $40.6M $34.3M $68.9M $80.4M $69.0M
Acquisitions $158M $122M $493M $6.6M $0.0M $128M $237M $0.0M $0.0M $2.5M
Share buybacks $137M $255M $328M $3.1M $53.2M $129M $258M $9.3M $5.1M $18.4M
Dividends paid $117M $120M $120M $125M $411M $143M $166M $149M $151M $154M
Dividends and buybacks $254M $376M $448M $128M $464M $272M $424M $158M $156M $173M
Balance sheet
Cash and short-term investments $28.6M $121M $33.9M $18.8M $16.6M $244M $86.8M $31.9M $71.6M $36.6M
Total debt $1.2B $1.4B $2.0B $1.6B $1.5B $2.3B $3.0B $2.6B $2.2B $2.1B
Finance lease liabilities $0.0M $0.0M $0.0M $0.0M $36.1M $33.4M $28.9M $16.9M $17.8M $14.5M
Current assets $1.0B $882M $886M $1.0B $1.2B $2.0B $2.0B $1.4B $980M $940M
Current liabilities $707M $545M $613M $621M $950M $1.1B $964M $774M $750M $740M
Inventory $395M $408M $481M $540M $622M $1.1B $1.3B $880M $588M $593M
Property and equipment, net $445M $468M $531M $546M $560M $622M $606M $610M $610M $632M
Total assets $2.8B $2.7B $3.1B $3.0B $3.4B $4.8B $4.3B $3.4B $2.9B $2.7B
Total liabilities $2.0B $2.1B $2.7B $2.3B $2.7B $3.8B $4.1B $3.7B $3.3B $3.1B
Shareholders' equity $715M $649M $355M $719M $697M $1.0B $148M βˆ’$267M βˆ’$391M βˆ’$358M
Margins
Gross margin 35.9% 36.8% 32.5% 32.3% 32.6% 29.8% 22.2% 18.5% 23.9% 30.6%
Operating margin 17.9% 16.4% 7.5% 13.0% 14.2% 14.7% βˆ’11.1% βˆ’4.9% 5.9% 10.5%
EBITDA margin 20.4% 19.2% 10.6% 15.8% 16.5% 16.6% βˆ’8.4% βˆ’2.3% 8.2% 12.7%
Net margin 12.6% 8.3% 2.4% 14.6% 9.4% 10.4% βˆ’11.2% βˆ’10.7% βˆ’1.0% 4.3%
FCF margin 7.4% 11.1% 10.3% 5.8% 12.0% 3.3% βˆ’6.2% 12.3% 16.4% 8.0%
Returns
Return on capital 15.7% 14.1% 9.3% 13.1% 19.5% 20.8% βˆ’11.2% βˆ’5.1% 8.0% 13.4%
Return on capital employed 22.6% 20.4% 8.6% 16.9% 24.2% 23.8% βˆ’12.4% βˆ’5.8% 8.8% 17.4%
Return on equity 47.2% 32.0% 12.7% 85.9% 54.7% 59.9% βˆ’75.4% β€” β€” β€”
Return on assets 11.9% 7.9% 2.2% 15.2% 12.1% 12.5% βˆ’9.6% βˆ’9.9% βˆ’1.1% 5.2%
Growth
Revenue growth βˆ’16.9% 5.4% 0.8% 18.5% 30.9% 19.2% βˆ’20.3% βˆ’9.5% 0.0% βˆ’3.9%
Net income growth 97.3% βˆ’30.8% βˆ’70.8% 623.2% βˆ’15.9% 32.3% βˆ’185.4% β€” β€” β€”
EPS growth 98.1% βˆ’28.7% βˆ’69.2% 630.4% βˆ’16.8% 31.6% βˆ’188.0% β€” β€” β€”
FCF growth 0.3% 58.1% βˆ’6.6% βˆ’32.8% 168.6% βˆ’66.8% βˆ’247.3% β€” 33.2% βˆ’53.1%
Share count change βˆ’0.3% βˆ’2.9% βˆ’5.2% βˆ’1.4% 1.1% 0.5% βˆ’3.0% 0.9% 1.4% 3.4%
Financial health
Net debt / EBITDA 2.3x 2.5x 7.1x 3.2x 2.2x 2.5x β€” β€” 7.5x 4.8x
Debt / equity 1.7x 2.2x 5.7x 2.3x 2.2x 2.3x β€” β€” β€” β€”
Interest coverage 7.1x 5.7x 2.3x 4.0x 7.4x 9.2x βˆ’3.7x βˆ’1.0x 1.3x 2.8x
Current ratio 1.5x 1.6x 1.5x 1.7x 1.3x 1.8x 2.1x 1.8x 1.3x 1.3x
Quick ratio 0.9x 0.9x 0.7x 0.8x 0.6x 0.8x 0.7x 0.7x 0.5x 0.5x
Capital allocation
Capex / revenue 2.3% 2.6% 2.6% 1.3% 1.5% 2.2% 2.9% 2.6% 2.4% 2.9%
Stock comp / revenue 0.6% 1.0% 1.5% 1.2% 1.4% 0.8% 0.9% 1.9% 2.3% 2.0%
Payouts / FCF 136.8% 127.9% 163.2% 69.2% 93.8% 165.4% β€” 36.2% 26.8% 63.1%
Quality scores
Piotroski F-score 6.0 6.0 5.0 7.0 6.0 5.0 3.0 4.0 5.0 6.0
Altman Z'' 3.3 3.4 2.2 3.5 3.2 3.6 1.7 1.3 1.2 1.6
Accruals ratio 2.7% βˆ’5.3% βˆ’9.6% 7.7% βˆ’5.3% 5.9% βˆ’6.8% βˆ’23.6% βˆ’22.4% βˆ’8.1%

Source: SEC EDGAR XBRL filings (CIK 0000825542). Data updated October 14, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open